Subscribe

BIO International Convention

Susan Ruediger on Pursuing Gene Therapies for CMT

BySusan Ruediger

July 13th 2022

Susan Ruediger, founder and chief mission officer, CMT Research Foundation, discussed the foundation’s mission.

Susan Ruediger

Connecting Patient Advocacy and Industry for Gene Therapy Development

BySusan Ruediger

June 28th 2022

Susan Ruediger, founder and chief mission officer, CMT Research Foundation, discussed the panel discussion she participated in at BIO 2022.

Trending on CGTlive®

Top News in Lymphoma Cell Therapy for World Lymphoma Awareness Day 2025

Duchenne Action Month 2025: Looking Back at News and Expert Insights

© 2025 MJH Life Sciences^®

All rights reserved.